Skip to content

Q&A: Key takeaways from Pharmapack

After Pharmapack 2026, Olivia Friett spoke to Orhan Caglayan, executive vice president of the Pharma Portfolio, Informa, about the key takeaways from the event.

Q&A: Key takeaways from Pharmapack
Published: | 3 min read

After Pharmapack 2026, Olivia Friett spoke to Orhan Caglayan, executive vice president of the Pharma Portfolio, Informa, about the key takeaways from the event. 

Now that Pharmapack has wrapped up, what were your biggest takeaways from this year’s event? 

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information